Topical estrogen accelerates hair regrowth in mice after chemotherapy-induced alopecia by favoring the dystrophic catagen response pathway to damage.

Estrogen receptor ligands are important modulators of skin physiology and are involved in the control of normal hair follicle cycling. Here, we have studied the effects of topically applied 17-beta-estradiol on pathologic hair follicle cycling as seen during chemotherapy-induced alopecia, one of the major unresolved problems of clinical oncology. For this study we employed a well-established murine model that mimics chemotherapy-induced alopecia in humans. For precisely quantifying the area of hair loss and hair regrowth in this model in vivo, we developed a simple planimetric assay (dotmatrix planimetry). We show that topical 17-beta-estradiol significantly alters the cycling response of murine follicles to cyclophosphamide, whereas the estrogen antagonist ICI 182.780 exerted no such effects. Initially, topical 17-beta-estradiol enhanced chemotherapy-induced alopecia significantly by forcing the follicles into the dystrophic catagen response pathway to hair follicle damage, whereas follicles treated by ICI 182.780 or vehicle shifted into the dystrophic anagen response pathway. Consequently, the regrowth of normally pigmented hair shafts after chemotherapy-induced alopecia was significantly accelerated in the 17-beta-estradiol treated group. Our data encourage one to explore topical estrogens as a potential stimulant for hair re-growth after chemotherapy-induced alopecia.

[1]  R. Paus,et al.  Estrogens and human scalp hair growth-still more questions than answers. , 2004, The Journal of investigative dermatology.

[2]  M. Thornton.  The biological actions of estrogens on skin , 2002, Experimental dermatology.

[3]  J. Gustafsson,et al.  Estrogen Receptor α, but not Estrogen Receptor β, is Involved in the Regulation of the Hair Follicle Cycling as well as the Thickness of Epidermis in Male Mice , 2002 .

[4]  P. Siock,et al.  Topical estrogens: their effects on connective tissue synthesis in hairless mouse skin , 2002, Archives of Dermatological Research.

[5]  M. Holick,et al.  A new strategy for modulating chemotherapy-induced alopecia, using PTH/PTHrP receptor agonist and antagonist. , 2001, The Journal of investigative dermatology.

[6]  R Paus,et al.  A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. , 2001, The Journal of investigative dermatology.

[7]  J. Thomsen,et al.  Mechanisms of estrogen action. , 2001, Physiological reviews.

[8]  J. Gustafsson,et al.  Estrogen receptor transcription and transactivation: Basic aspects of estrogen action , 2000, Breast Cancer Research.

[9]  M. Calvin.  Oestrogens and wound healing. , 2000, Maturitas.

[10]  R. Smart,et al.  17β-Estradiol and ICI-182780 regulate the hair follicle cycle in mice through an estrogen receptor-α pathway , 2000 .

[11]  R. Smart,et al.  Effects of 17-beta-estradiol and ICI 182 780 on hair growth in various strains of mice. , 1999, The journal of investigative dermatology. Symposium proceedings.

[12]  C. Webb,et al.  Estrogen hits the surface , 1999, Nature Medicine.

[13]  R Paus,et al.  A comprehensive guide for the recognition and classification of distinct stages of hair follicle morphogenesis. , 1999, The Journal of investigative dermatology.

[14]  R Paus,et al.  The biology of hair follicles. , 1999, The New England journal of medicine.

[15]  D. Tobin,et al.  Do hair bulb melanocytes undergo apoptosis during hair follicle regression (catagen)? , 1998, The Journal of investigative dermatology.

[16]  R. Paus,et al.  Reduction of intrafollicular apoptosis in chemotherapy-induced alopecia by topical calcitriol-analogs. , 1998, The Journal of investigative dermatology.

[17]  R. Paus,et al.  Hair growth modulation by topical immunophilin ligands: induction of anagen, inhibition of massive catagen development, and relative protection from chemotherapy-induced alopecia. , 1997, The American journal of pathology.

[18]  R. Smart,et al.  An estrogen receptor pathway regulates the telogen-anagen hair follicle transition and influences epidermal cell proliferation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[19]  R. Paus,et al.  Topical calcitriol enhances normal hair regrowth but does not prevent chemotherapy-induced alopecia in mice. , 1996, Cancer research.

[20]  M. Mihm,et al.  Pharmacological disruption of hair follicle pigmentation by cyclophosphamide as a model for studying the melanocyte response to and recovery from cytotoxic drug damage in situ. , 1996, The Journal of investigative dermatology.

[21]  A. Philips,et al.  Genomic cross-talk between the estrogen receptor and growth factor regulatory pathways in estrogen target tissues. , 1994, Seminars in cancer biology.

[22]  S. Eichmüller,et al.  Chemotherapy-induced alopecia in mice. Induction by cyclophosphamide, inhibition by cyclosporine A, and modulation by dexamethasone. , 1994, The American journal of pathology.

[23]  R. Paus,et al.  Telogen skin contains an inhibitor of hair growth , 1990, The British journal of dermatology.

[24]  A. Hood,et al.  Cutaneous complications of chemotherapeutic agents. , 1983, Journal of the American Academy of Dermatology.

[25]  F. Ebling,et al.  The activity of hair follicles and their response to oestradiol in the guinea-pig Cavia porcellus L. , 1972, Journal of anatomy.

[26]  O. Braun-Falco.  Klinik und Pathomechanismus der Endoxan-Alopecie als Beitrag zum Wesen cytostatischer Alopecien , 1961, Archiv für klinische und experimentelle Dermatologie.

[27]  E. Johnson.  Quantitative studies of hair growth in the albino rat. III. The role of the adrenal glands. , 1958, The Journal of endocrinology.

[28]  E. Johnson.  Quantitative studies of hair growth in the albino rat. I. Normal males and females. , 1958, The Journal of endocrinology.

[29]  T. Nay,et al.  Growth of the mouse coat. II. Effect of sex and pregnancy. , 1953, Australian journal of biological sciences.

[30]  C. W. Emmens.  THE ENDOCRINE SYSTEM AND HAIR GROWTH IN THE RAT , 1942 .

[31]  W. Gardner,et al.  Inhibition of Hair Growth in Dogs Receiving Estrogens * , 1940, The Yale journal of biology and medicine.

[32]  R Paus,et al.  Controls of hair follicle cycling. , 2001, Physiological reviews.

[33]  J. Kievit,et al.  Effect of peri-operative chemotherapy on the quality of life of patients with early breast cancer. , 1990, European journal of cancer.

[34]  V. Devita,et al.  Cancer : Principles and Practice of Oncology , 1982 .

[35]  U. Schumacher-Stock.  Estrogen Treatment of Hair Diseases , 1981 .